Cargando…
TP53-mediated therapy-related clonal hematopoiesis contributes to doxorubicin-induced cardiomyopathy by augmenting a neutrophil-mediated cytotoxic response
Therapy-related clonal hematopoiesis (t-CH) is often observed in cancer survivors. This form of clonal hematopoiesis typically involves somatic mutations in driver genes that encode components of the DNA damage response and confer hematopoietic stem and progenitor cells (HSPCs) with resistance to th...
Autores principales: | Sano, Soichi, Wang, Ying, Ogawa, Hayato, Horitani, Keita, Sano, Miho, Polizio, Ariel H., Kour, Anupreet, Yura, Yoshimitsu, Doviak, Heather, Walsh, Kenneth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8410064/ https://www.ncbi.nlm.nih.gov/pubmed/34236050 http://dx.doi.org/10.1172/jci.insight.146076 |
Ejemplares similares
-
The Cancer Therapy-Related Clonal Hematopoiesis Driver Gene Ppm1d Promotes Inflammation and Non-Ischemic Heart Failure in Mice
por: Yura, Yoshimitsu, et al.
Publicado: (2021) -
Experimental
ASXL1
‐Mediated Clonal Hematopoiesis Promotes Inflammation and Accelerates Heart Failure
por: Min, Kyung‐Duk, et al.
Publicado: (2022) -
Clonal Hematopoiesis: A New Step Linking Inflammation to Heart Failure
por: Yura, Yoshimitsu, et al.
Publicado: (2020) -
Employing the CRISPR-Cas System for Clonal Hematopoiesis Research
por: Ogawa, Hayato, et al.
Publicado: (2021) -
JAK2(V617F)-Mediated Clonal Hematopoiesis Accelerates Pathological Remodeling in Murine Heart Failure
por: Sano, Soichi, et al.
Publicado: (2019)